chrX-153691562-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_005629.4(SLC6A8):c.644+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,209,866 control chromosomes in the GnomAD database, including 1 homozygotes. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000071 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000010 ( 1 hom. 2 hem. )
Consequence
SLC6A8
NM_005629.4 intron
NM_005629.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0680
Publications
1 publications found
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
- creatine transporter deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-153691562-G-C is Benign according to our data. Variant chrX-153691562-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 702153.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC6A8 | NM_005629.4 | c.644+9G>C | intron_variant | Intron 3 of 12 | ENST00000253122.10 | NP_005620.1 | ||
| SLC6A8 | NM_001142805.2 | c.644+9G>C | intron_variant | Intron 3 of 12 | NP_001136277.1 | |||
| SLC6A8 | NM_001142806.1 | c.299+9G>C | intron_variant | Intron 3 of 12 | NP_001136278.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000706 AC: 8AN: 113309Hom.: 0 Cov.: 24 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
113309
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000222 AC: 4AN: 180354 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
4
AN:
180354
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1096557Hom.: 1 Cov.: 31 AF XY: 0.00000552 AC XY: 2AN XY: 362545 show subpopulations
GnomAD4 exome
AF:
AC:
11
AN:
1096557
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
362545
show subpopulations
African (AFR)
AF:
AC:
11
AN:
26377
American (AMR)
AF:
AC:
0
AN:
35187
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19367
East Asian (EAS)
AF:
AC:
0
AN:
30198
South Asian (SAS)
AF:
AC:
0
AN:
54103
European-Finnish (FIN)
AF:
AC:
0
AN:
39937
Middle Eastern (MID)
AF:
AC:
0
AN:
3916
European-Non Finnish (NFE)
AF:
AC:
0
AN:
841439
Other (OTH)
AF:
AC:
0
AN:
46033
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000706 AC: 8AN: 113309Hom.: 0 Cov.: 24 AF XY: 0.0000282 AC XY: 1AN XY: 35461 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
113309
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
35461
show subpopulations
African (AFR)
AF:
AC:
8
AN:
31232
American (AMR)
AF:
AC:
0
AN:
10856
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2654
East Asian (EAS)
AF:
AC:
0
AN:
3600
South Asian (SAS)
AF:
AC:
0
AN:
2829
European-Finnish (FIN)
AF:
AC:
0
AN:
6358
Middle Eastern (MID)
AF:
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
AC:
0
AN:
53321
Other (OTH)
AF:
AC:
0
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Creatine transporter deficiency Benign:1
Jun 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.